The effects of hormone replacement therapy on myocardial performance in early postmenopausal women

References

• Vitale C, Miceli M, Rosano GM. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 2007;10(Suppl 2):16–20
   PubMed Web of Science ®Google Scholar
• Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007;10(Suppl 1):19–24
   PubMed Web of Science ®Google Scholar
• Collins P, Rosano G, Casey C, et al Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric 2007;10:508–526
   PubMed Web of Science ®Google Scholar
• Lobo RA. Postmenopausal hormones and coronary artery disease: potential benefits and risks. Climacteric 2007;10(Suppl 2):21–26
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady P, Bush T, et al Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605–613
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–1712
   PubMed Web of Science ®Google Scholar
• Vickers MR, MacLennan AH, Lawton B, et al Main morbidities recorded in the Women's International study of Long Duration Oestrogen after Menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007;335:239
   PubMed Web of Science ®Google Scholar
• Prelevic GM, Beljic T. The effect of estrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 1994;20:37–44
   PubMed Web of Science ®Google Scholar
• Pines A, Fisman EZ, Drory Y, et al Menopause-induced changes in Doppler derived parameters of aortic flow in healthy women. Am J Cardiol 1992;69:1104–1106
   PubMed Web of Science ®Google Scholar
• Pines A, Fisman EZ, Levo Y, et al Menopause-induced changes in left ventricular wall thickness. Am J Cardiol 1993;72:240–241
   PubMed Web of Science ®Google Scholar
• Duzenli MA, Ozdemir K, Sokmen A, et al Effects of menopause on the myocardial velocities and myocardial performance index. Circ J 2007;11:1728–1733
   Google Scholar
• Pearlman AS, Gadrin JM, Martin RP, et al Guidelines for optimal physician training in echocardiography Recommendations of the American Society of Echocardiography Committee for Physician training in Echocardiography. Am J Cardiol 1987;60:158–163
   PubMed Web of Science ®Google Scholar
• Okin PM, Kligfeld P. Gender-specific criteria and performance of the exercise electrocardiogram. Circulation 1995;92:1209–1216
   PubMed Web of Science ®Google Scholar
• Grohe C, Kahlert S, Lobbert K, et al Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997;416:107–112
   PubMed Web of Science ®Google Scholar
• Lin AL, Gonzales R Jr, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986;6:495–504
   PubMedGoogle Scholar
• Taşkın O, Gokdeniz R, Muderrisoglu H, et al The effects of hormone on echocardiographic basic cardiac functions in postmenopausal women. Hum Reprod 1998;13:2399–2401
   PubMed Web of Science ®Google Scholar
• Sites CK, Tischler MD, Blackman JA, et al Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril 1999;71:137–143
   PubMed Web of Science ®Google Scholar
• Beljic T, Babic D, Marinkovic J, Prelevic GM. The effect of hormone replacement therapy on diastolic left ventricular function in hypertensive and normotensive postmenopausal women. Maturitas 1998;29:229–238
   PubMed Web of Science ®Google Scholar
• Fak AS, Erenus M, Tezcan H, Caymaz O, Oktay S, Oktay A. Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction. Fertil Steril 2000;73:66–71
   PubMed Web of Science ®Google Scholar
• Alecrin IN, Aldrighi JM, Caldas MA, Gebara OC, Lopes NH, Ramires JA. Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart 2004;90:777–781
   PubMed Web of Science ®Google Scholar
• Leonardo F, Medeirus C, Rosano GM, et al Effect of acute administration of estradiol 17 beta on aortic blood flow in menopausal women. Am J Cardiol 1997;80:791–793
   PubMed Web of Science ®Google Scholar
• Snabes MC, Payne JP, Kopelen HA, Dunn JK, Young RL, Zoghbi WA. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Obstet Gynecol 1997;89:332–339
   PubMed Web of Science ®Google Scholar
• Vogelvang TE, Mijatovic V, Kamp O, et al Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: Two randomized, placebo-controlled, 2-year studies. Am J Obstet Gynecol 2002;186:729–736
   PubMed Web of Science ®Google Scholar
• Waggoner AD, Bierig SM. Tissue Doppler imaging: useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr 2001;14:1143–1152
   PubMed Web of Science ®Google Scholar
• Yamada H, Oki T, Tabata T, Iuchi A, Ito S. Assessment of left ventricular systolic wall motion velocity with pulsed tissue Doppler imaging: comparison with peak dP/dt of the left ventricular pressure curve. J Am Soc Echocardiogr 1998;11:442–449
   PubMed Web of Science ®Google Scholar
• Tei C, Ling LH, Hodge DO, et al New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normal and dilated cardiomyopathy. J Cardiol 1995;26:357–366
   PubMedGoogle Scholar
• Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived MPI combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998;81:1157–1161
   PubMed Web of Science ®Google Scholar
• Dagdelen S, Eren N, Karabulut H, Caglar N. Importance of the index of myocardial performance in evaluation of left ventricular function. Echocardiogarphy 2002;19:273–278
   PubMed Web of Science ®Google Scholar
• Ozdemir K, Mil S, Duzenli A, et al Effect of preload and heart rate on the Doppler and tissue Doppler-derived myocardial performance index. Clin Cardiol 2007;7:342–348
   Google Scholar
• Mercuro G, Zoncu S, Paoletti AM, Melis GB, Vacca AM, Cherchi A. Study of myocardial contractility by pulsed wave Doppler tissue imaging does not reveal an inotropic effect of estrogen at physiologic dose. Am J Cardiol 1999;83:1677–1679
   PubMed Web of Science ®Google Scholar
• Gokce M, Karahan B, Erdol C, Kasap H, Ozdemirci S. Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction. Am J Ther 2003;10:104–111
   PubMedGoogle Scholar
• Aldrighi JM, Alecrin IN, Caldas MA, Gebara OC, Ramires JA, Rosano GM. Effects of estradiol on myocardial global performance index in hypertensive postmenopausal women. Gynecol Endocrinol 2004;19:282–292
   PubMed Web of Science ®Google Scholar
• Ozdemir K, Celik C, Altunkeser BB, et al Effect of postmenopausal hormone replacement therapy on cardiovascular performance. Maturitas 2004;47:107–113
   PubMed Web of Science ®Google Scholar
• Voutilainen S, Hippelainen M, Hulka S, Karppinen K, Ventila M, Kupari M. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol 1993;71:614–617
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, et al Menopause is associated with endothelial dysfunction. Hypertension 1996;28:576–582
   PubMed Web of Science ®Google Scholar
• Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO 3rd. Acute vascular effects estrogen in postmenopausal women. Circulation 1994;90:786–791
   PubMed Web of Science ®Google Scholar
• Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time menopause. Lancet 1991;338:839–842
   PubMed Web of Science ®Google Scholar
• Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17β-estradiol on contraction, Ca 21 current and intracellular free Ca 21 in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739–745
   PubMed Web of Science ®Google Scholar
• Stevenson JC, Oladipo A, Manassiev N, Whitehead MI, Guilford S, Proudler AJ. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. Br J Haematol 2004;124:802–808
   PubMed Web of Science ®Google Scholar
• Mercuro G, Saiu F, Deidda M, Mercuro S, Vitale C, Rosano GM. Impairment of physical exercise capacity in healthy postmenopausal women. Am Heart J 2006;4:923–927
   Google Scholar
• Mercuro G, Saiu F, Deidda M, Mercuro S, Vitale C, Rosano GM. Effect of hormone therapy on exercise capacity in early postmenopausal women. Obstet Gynecol 2007;4:780–787
   Google Scholar
• Arias RD. Cardiovascular health and the menopause: the gynecologist as the patients' interface. Climacteric 2006;9(Suppl 1):6–12
   PubMedGoogle Scholar
• Pines A, Sturdee DW, MacLennan AH, Schneider HP, Burger H, Fenton A. The heart of the WHI study: time for hormone therapy policies to be revised. Climacteric 2007;10:267–269
   PubMed Web of Science ®Google Scholar
• Alexandersen P, Tanko LB, Bagger YZ, Qin G, Christiansen C. The long-term impact of 2–3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric 2006;9:108–118
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Women's Health 2006;15:35–44
   PubMed Web of Science ®Google Scholar
• Clarkson TB, Appt SE. Controversies about HRT – lessons from monkey models. Maturitas 2005;51:64–74
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Greyber E, Salpeter EE. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006;21:363–366
   PubMed Web of Science ®Google Scholar
• Depypere HT, Tummers P, De Bacquer D, De Backer G, Do M, Dhont M. Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy. Climacteric 2007;10:238–243
   PubMed Web of Science ®Google Scholar
• Board of the International Menopause Society, Pines A, Sturdee DW, Birkhäuser MH, Schneider HP, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181–194
   PubMed Web of Science ®Google Scholar